Project Grant R21AA030360

Award Date 8/2/23
Completion Date 7/31/25
Dollars Obligated $424K
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Washington, DC, USA
Similar Awards
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will provide $159,056 to The Washington University in St. Louis to investigate the role of a novel dynorphinergic circuit in the brain in driving binge-like alcohol drinking during persistent pain and protracted opioid abstinence. The research will use a combination of behavioral, photometric, and chemogenetic techniques to test the hypothesis that this...
This $164,349 Project Grant awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund research at Virginia Commonwealth University (VCU) to characterize the sex-specific genetic architecture of alcohol use disorders (AUD) with comorbid major depressive disorder (MDD). The research aims to leverage data from 10 longitudinal cohorts to analyze the interacting effects of sex, genetics, and comorbid MDD on the trajectory...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, provides $503,750.00 to investigate the impact of chronic pain on alcohol consumption among heavy drinkers with temporomandibular disorder (TMD). The primary objective is to assess the effect of pain on drinking topography, both in a controlled laboratory setting using virtual reality and in daily life through ecological...
This Project Grant award of $594,784 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund a multi-omic study to investigate the molecular pathology of alcohol use disorder (AUD). The project, led by Yale University, aims to identify novel transcriptomic and epigenetic changes in brain regions associated with AUD. The study will analyze gene expression and DNA methylation patterns across 8 brain areas from 341 postmortem...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) aims to identify the genetic mechanisms underlying alcohol sensitivity and tolerance in both humans and mice. The award, totaling $574,808 and commencing in September 2024, will fund a systematic and translational research strategy involving the following key elements: Genome-wide association studies (GWAS) of alcohol sensitivity and tolerance in European and...
This federal Project Grant award of $194,551 was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to The Medical University of South Carolina. The award will fund research from September 1, 2024 to August 31, 2026 to investigate the impact of adolescent intermittent ethanol exposure on parvalbumin interneuron regulation of a prelimbic to ventrolateral periaqueductal gray pathway and how this affects pain processing and...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under CFDA Program 93.273 - Alcohol Research Programs provides $497,581.76 to Yale University to conduct research investigating avoidance learning and pain circuit dysfunction in alcohol use disorders (AUD). The key objectives of this 3-year project are to: 1) characterize dysfunctions in brain circuits supporting pain reactivity and cognitive control during avoidance learning in AUD patients...
This federal Project Grant award, provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), supports research aimed at understanding the neural intersection of chronic alcohol exposure and pain. The total award amount is $144,362.00 and the project period runs from July 23, 2024 to June 30, 2027. The primary objectives of this grant are to: 1) Determine the activity of parabrachial nucleus (PBN) neurons expressing neuropeptide Y...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, provides $143,784.00 to Louisiana State University Health Sciences Center New Orleans to conduct research on the effects of adolescent opioid exposure on alcohol-induced hyperalgesia (increased pain sensitivity) in adult mice. The key objectives of this research project are to test the hypothesis that early-life exposure to opioids...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) has awarded a $152,000 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Des Moines University Osteopathic Medical Center (DMU) to study the role of GLUD1 receptors in regulating structural plasticity during chronic ethanol exposure and withdrawal. The two-year grant, awarded on September 1, 2023, will support DMU's research aimed at understanding how GLUD1 receptor function and expression influence dendritic spine...

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $424,194 Project Grant under the Alcohol Research Programs (CFDA 93.273) to George Washington University (The) to conduct research on the genetic architecture underlying the comorbidity of alcohol use disorder (AUD) and chronic pain (CP). The project aims to: 1) Estimate the shared genetic variance contributing to AUD and CP phenotypes and the unique genetic variance for each, 2) Determine the extent to which AUD-CP comorbidity is explained by shared genetics versus a causal relationship, and 3) Explore contextual moderators impacting genetic contributions to AUD-CP comorbidity.

The university will employ advanced statistical genetics methods, including genome-wide structural equation modeling, pairwise genome-wide association studies, Mendelian randomization, and genome-wide complex trait analysis, to address these research objectives. The University of Missouri System is a sub-awardee on the project, contributing its expertise in this area of study. This research seeks to advance the understanding of genetic and environmental factors underlying the co-occurrence of AUD and chronic pain, with the goal of informing future efforts to develop more effective prevention and treatment strategies.

Generated 7/16/24, 2:31 AM